NEWTOWN, Pa.–BioClinica Inc. has announced the selection by Worldwide Clinical Trials Inc. of BioClinica's OnPoint clinical trial management system (CTMS) to support international studies involving all phases of development in a range of therapeutic areas. OnPoint offers end-to-end clinical trial management, maintaining role-based access control throughout the duration of the process. It provides tools for planning, startup and conducting studies, and for completing monitoring and regulatory compliance activities. The system utilizes Microsoft SharePoint to enable connectivity in multisite study environments.
"We believe well-integrated technologies enhance clinical development, and the decision to replace our existing trial management system with BioClinica's OnPoint reflects this. It also gives us broader functionality along with predictable pricing. After conducting an extensive evaluation of industry-leading CTMS providers, we selected OnPoint for its flexibility, scalability, and superior technical support," said Tom Wardle, chief operating officer at Worldwide Clinical Trials.